RaQualia Pharma Inc Market Research and Development, Pipeline Review 2016

1. RaQualia Pharma Inc Market Outlook, Business Overview and Analysis, Research and Development, Pipeline Review 2016 Summary Global Markets Direct's, 'RaQualia Pharma Inc. - Product Pipeline Review - 2016', provides an overview of the RaQualia Pharma Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by RaQualia Pharma Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Access Full Report with TOC @ http://www.radiantinsights.com/research/raqualia-pharma-inc-product- pipeline-review-2016 The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of RaQualia Pharma Inc. - The report provides overview of RaQualia Pharma Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses RaQualia Pharma Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

2. - The report features RaQualia Pharma Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate RaQualia Pharma Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for RaQualia Pharma Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding RaQualia Pharma Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Buy a Sample copy of This Report @ http://www.radiantinsights.com/research/raqualia-pharma-inc-product- pipeline-review-2016/request-sample Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 RaQualia Pharma Inc. Snapshot 5 RaQualia Pharma Inc. Overview 5 Key Information 5 Key Facts 5 RaQualia Pharma Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 RaQualia Pharma Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 RaQualia Pharma Inc. - Pipeline Products Glance 11 RaQualia Pharma Inc. - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 RaQualia Pharma Inc. - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 RaQualia Pharma Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 RaQualia Pharma Inc. - Drug Profiles 15 tegoprazan 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Access Full Report with TOC @ http://www.radiantinsights.com/research/raqualia-pharma-inc-product- pipeline-review-2016 About Us:

3. Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. Contact Details: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc 28 2nd Street, Suite 3036 San Francisco, CA 94105 United States Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Website: http://www.radiantinsights.com/ Email: sales@radiantinsights.com Visit our Blog: http://chemicalsandmaterialsri.blogspot.com